Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New KRAS protein degraders synthesized at BioTheryX

May 19, 2022

Mission Therapeutics patents USP30 inhibitors

May 18, 2022

University of Ljubljana presents dual TLR7/NOD2 agonists

May 18, 2022

Nanocapsules efficiently deliver single CRISPR-Cas9 across the blood-brain barrier

May 17, 2022

Suzhou Zelgen Biosciences patents G12C mutant GTPase KRAS inhibitors

May 17, 2022

New RET inhibitors synthesized at Shanghai LiteDD

May 17, 2022

Lhotse Bio discovers lysophosphatidic acid receptor 1 antagonists

May 17, 2022

Korea University Research and Business Foundation presents new apoptosis inducers

May 16, 2022

New compounds targeting the estrogen receptor divulged by Sanofi

May 16, 2022

Calithera Biosciences presents new L-amino acid oxidase inhibitors

May 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...